03/07/2021
How is CJD diagnosed?
Several tests can help diagnose CJD.
Electroencephalography (EEG), which records the brain’s electrical pattern, can be particularly valuable because it shows a specific type of abnormality in major but not all types of CJD.
Cerebrospinal fluid-based tests. In April 2015, the National Prion Disease Pathology Surveillance Center began reporting a new diagnostic test for human prion diseases, called second generation Real Time-Quaking-Induced Conversion (RT-QuIC). RT-QuIC is based on an ultrasensitive detection of the pathogenic prion protein in the cerebrospinal fluid of individuals affected by CJD and other forms of human prion diseases. This new advanced test demonstrates a very high sensitivity and specificity of the disease. RT-QuIC differs from traditional surrogate markers of prion disease –14-3-3 and tau proteins—in that it detects directly a disease-defining pathogenic prion protein as opposed to a surrogate marker of rapid neurodegeneration. Detection of these traditional surrogate marker proteins is accurate in approximately three-fourths of cases.
Magnetic resonance imaging (MRI) has recently been found to be accurate in about 90 percent of cases.
The only way to confirm a diagnosis of CJD is by brain biopsy or autopsy. In a brain biopsy, a neurosurgeon removes a small piece of tissue from the person’s brain so that it can be examined by a neuropathologist. This procedure may be dangerous for the individual, and the operation does not always obtain tissue from the affected part of the brain. Because a correct diagnosis of CJD does not help the individual, a brain biopsy is discouraged unless it is needed to rule out a treatable disorder. In an autopsy, the whole brain is examined after death.
top
How is the disease treated?
Currently, there is no treatment that can cure or control CJD, although studies of a variety of drugs are now in progress. Current treatment for CJD is aimed at easing symptoms and making the person as comfortable as possible. Op**te drugs can help relieve pain if it occurs, and the drugs clonazepam and sodium valproate may help relieve myoclonus. During later stages of the disease, intravenous fluids and artificial feeding also may be used.
top
How can people avoid spreading the disease?
To reduce the already very low risk of CJD transmission from one person to another, people should never donate blood, tissues, or organs if they have suspected or confirmed CJD, or if they are at increased risk because of a family history of the disease, a dura mater graft, or other factor.
Normal sterilization procedures such as cooking, washing, and boiling do not destroy prions. Although there is no evidence that caregivers, healthcare workers, and those who prepare bodies for funerals and cremation have increased risk of prion diseases when compared to general population, they should take the following precautions when they are working with a person with CJD:
Cover cuts and abrasions with waterproof dressings.
Wear surgical gloves when handling the person’s tissues and fluids or dressing any wounds.
Avoid cutting or sticking themselves with instruments contaminated by the person’s blood or other tissues.
Use disposable bedclothes and other cloth for contact with the person.If disposable materials are not available, regular cloth should be soaked in undiluted chlorine bleach for an hour or more, and then washed in a normal fashion after each use.
Use face protection if there is a risk of splashing contaminated material such as blood or cerebrospinal fluid.
Soak instruments that have come in contact with the person in undiluted chlorine bleach for an hour or more, then use an autoclave (pressure cooker) to sterilize them in distilled water for at least one hour at 132 - 134 degrees Celsius.
top
What research is taking place?
The mission of the National Institute of Neurological Disorders and Stroke (NINDS) is to seek fundamental knowledge of the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. The NINDS is a component of the National Institutes of Health (NIH), the leading supporter of biomedical research in the world.
Other NIH Institutes, including the National Institute of Allergy and Infectious Diseases and the National Institute on Aging, also conduct research on CJD.
Researchers are examining and characterizing the prions associated with CJD and other human and animal prion diseases and trying to discover factors that influence prion infectivity and transmission, and how the disorder damages the brain. For example, researchers are investigating the cellular mechanisms involved in abnormal prion formation and accumulation, as well as their replication by select cellular subsets in the brain. Other projects are examining how abnormal prions cross the protective blood-brain barrier and spread throughout the central nervous system, and tests that measure the biological activity of prions. Findings may identify new therapeutic targets to treat prion diseases.
More information about CJD research supported by NINDS and other NIH Institutes and Centers can be found using NIH RePORTER, a searchable database of current and past research projects supported by NIH and other federal agencies. RePORTER also includes links to publications and resources from these projects.
top
How can I help research?
Scientists are conducting biochemical analyses of brain tissue, blood, spinal fluid, urine, and serum in the hope of determining the nature of the transmissible agent or agents causing CJD. To help with this research, they are seeking biopsy and autopsy tissue, blood, and cerebrospinal fluid from individuals with CJD and related diseases. The following investigators have expressed an interest in receiving such material: